Evidence map›Paper›PMID 41806055›Full record

ArticleJournal of hematopathology2026

ALK-positive, EBV-positive Large B-cell lymphoma in an HIV patient: a diagnostic pitfall mimicking plasmablastic lymphoma.

Chutima Pinnark Surintrspanont, Benjamaporn Buasatit, Narittee Sukswai, Suphakit Hemla, Chinachote Teerapakpinyo, Shanop Shuangshoti

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Journal of hematopathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chutima Pinnark SurintrspanontInstitute of Pathology, Department of Medical Services, Ministry of Public Health, Bangkok, Thailand. memay.mamie@gmail.com.ORCID 0000-0003-4349-5317
Benjamaporn BuasatitDepartment of Medicine, King Narai Hospital, Lopburi, Thailand.
Narittee SukswaiPrecision Pathology of Neoplasia Research Group, Department of Pathology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.ORCID 0000-0001-8513-8153
Suphakit HemlaChula GenePRO Center, Chulalongkorn University, The King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Chinachote TeerapakpinyoChula GenePRO Center, Chulalongkorn University, The King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Shanop ShuangshotiChula GenePRO Center, Chulalongkorn University, The King Chulalongkorn Memorial Hospital, Bangkok, Thailand.ORCID 0000-0003-3416-337X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ALK-positive large B-cell lymphoma (ALK + LBCL) is a rare subtype of large B-cell lymphoma characterized by plasmablastic morphology, intra-sinusoidal or sheet-like proliferation, loss of pan-B-cell markers, and expression of plasmacytic markers. According to WHO classification, CD30 expression is generally absent and Epstein-Barr virus (EBV) infection is not detected [1,2,5] . We aim to report the first case of ALK-positive, EBV-positive large B-cell lymphoma (ALK + EBV + LBCL) in an HIV-infected patient. A 60-year-old Thai male with HIV infection and severe immunosuppression (CD4 count: 93 cells/mm

Indexed as

Anaplastic Lymphoma KinaseEpstein-Barr Virus InfectionsHerpesvirus 4, HumanHIV InfectionsLymphoma, AIDS-RelatedLymphoma, Large B-Cell, DiffusePlasmablastic LymphomaDiagnosis, DifferentialHumansMaleMiddle AgedALK protein, humanAnaplastic Lymphoma KinaseALKALK-positive large B-cell lymphomaEBERHIVPlasmablastic lymphoma

Identifiers

PMID41806055

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.